首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Quarterly journal of nuclear medicine and molecular imaging

缩写:Q J NUCL MED MOL IM

ISSN:1824-4785

e-ISSN:1827-1936

IF/分区:1.4/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引430
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Vincenzo Scialò,Federica Brilli,Costanza Lisi et al. Vincenzo Scialò et al.
To review the current and emerging role of advanced cardiovascular imaging modalities for the detection, characterization, and follow-up of cardiotoxicity in pediatric oncology patients, in light of recent cardio-oncology guidelines. This n...
Luca Guerra,Domenico Albano Luca Guerra
Pediatric non-Hodgkin lymphoma (NHL) is an aggressive and heterogeneous malignancy with high rates of extranodal involvement. Accurate staging and response assessment are crucial, yet challenging. While [18F]FDG PET/CT is a cornerstone in a...
Albrecht Betrains,Steven Vanderschueren,Chantal P Rovers et al. Albrecht Betrains et al.
In this review we summarize the current knowledge on fever of unknown origin (FUO). Fever of unknown origin remains a diagnostic challenge even despite increasing diagnostic possibilities since its first definition. Uniform definition of FU...
Domenico Albano,Carlo Rodella,Andrea Guarneri et al. Domenico Albano et al.
18F fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) has established itself as a fundamental non invasive diagnostic technique in the investigation of patients with fever (FUO) and inflammation of unkn...
Domenico Albano,Alessio Rizzo,Carlo Rodella et al. Domenico Albano et al.
Positron emission tomography/computed tomography (PET/CT) with 2-[fluorine-18]fluoro-2-deoxy-D-glucose ([18F]-FDG) is a well-established imaging tool in adult oncology and is increasingly utilized also in pediatric oncology due to its abili...